{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022978","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.506830+00:00","generated_at":"2026-05-17T15:12:16.190426+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nephros Q2 net rev $4.4M (+36% YoY); net income $237k vs loss $289k; 3rd consecutive profitable quarter","bullets":["Net revenue $4.4M, up 36% YoY from $3.3M; net income $237k vs net loss $289k.","Adjusted EBITDA $355k vs $(133k); gross margin improved to 63% from 59%.","Six-month net income $795k vs loss $458k; revenue $9.3M (+37% YoY).","Programmatic sales all-time high; largest dialysis filtration PO in company history.","Cash $5.1M, debt-free; active-site counts at all-time highs."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022978","json":"https://secwatch.observer/filing/0001641172-25-022978.json","markdown":"https://secwatch.observer/filing/0001641172-25-022978.md","text":"https://secwatch.observer/filing/0001641172-25-022978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000164117225022978/0001641172-25-022978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000164117225022978/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:12:16.190426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}